Health Canada — Medical Devices · Canada · 2019-03-01 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Luminex received customer complaints regarding xTAG Gastrointestinal Pathogen Panel (GPP) reporting lower MS2 MFI values. Investigational testing has determined that this is due to the variability of conductivity found in a lot of xTAG GPP Reporter Buffer, a component of the xTAG Gastrointestinal Pathogen Panel (GPP) kit. The potential impact of xTAG GPP Reporter Buffer with low conductivity on the xTAG GPP assay is that when testing patient specimens near the limit of detection (LoD) the assay has a remote possibility to generate false negative calls.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.